Literature DB >> 3012868

3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis.

J L Castrillo, D Vanden Berghe, L Carrasco.   

Abstract

3-Methylquercetin (3MQ) is a natural compound isolated from Euphorbia grantii that selectively inhibits poliovirus replication, but has no effect on encephalomyocarditis virus. When the compound is present from the beginning of infection, the bulk of viral protein synthesis is prevented, but the shut-off of host protein synthesis still occurs. Addition of 3MQ 3 hr after infection has a slight effect on viral protein synthesis, suggesting that this compound blocks a step of viral replication different from translation. Indeed, poliovirus RNA synthesis is potently blocked by 3MQ, i.e., 50% inhibition at 2 micrograms/ml (6.3 X 10(-6) M). No effect on encephalomyocarditis, nor on cellular RNA synthesis is observed even at 20 micrograms/ml. The inhibitory effect of 3MQ is reversible, since cells treated with this compound from the beginning of infection start to synthesize viral RNA and proteins when the compound is removed. Strikingly, other natural compounds structurally related to 3-methylquercetin such as quercetin, naringenin, naringin, morin, catechin, kaempferol, myricetin, phloretin, phlorizdin, and rutin do not block poliovirus replication.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012868     DOI: 10.1016/0042-6822(86)90386-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol.

Authors:  P L Rodriguez; L Carrasco
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection.

Authors:  A M Bonneau; N Sonenberg
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

3.  Action of 3-methylquercetin on poliovirus RNA replication.

Authors:  J L Castrillo; L Carrasco
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Antipoliovirus activity of isothiazole derivatives: mode of action of 5,5'-diphenyl-3,3'-diisothiazole disulfide (DID).

Authors:  A Garozzo; M R Pinizzotto; F Guerrera; G Tempera; A Castro; E Geremia
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179.

Authors:  I V Sandoval; L Carrasco
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro.

Authors:  C Conti; D Genovese; R Santoro; M L Stein; N Orsi; L Fiore
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

7.  6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.

Authors:  M E González; M J Almela; M Yacout; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Mechanism of action of the antiherpesvirus biflavone ginkgetin.

Authors:  K Hayashi; T Hayashi; N Morita
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

9.  Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage.

Authors:  A Irurzun; S Sánchez-Palomino; I Novoa; L Carrasco
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena.

Authors:  R Guinea; L Carrasco
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.